Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Genscript Biotech Corporation Governance Information 2025

Mar 11, 2025

49993_rns_2025-03-11_eb51204e-7158-47c3-ab72-23d1115b467e.pdf

Governance Information

Open in viewer

Opens in your device viewer

G

Genscript Biotech Corporation

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1548)

LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

The members of the board of directors (the "Board") of Genscript Biotech Corporation (the "Company") are set out below:

Executive Directors

Dr. Fangliang Zhang ("Dr. Frank Zhang")

Mr. Jiange Meng ("Mr. Robin Meng") (Chairman)

Ms. Ye Wang ("Ms. Sally Wang") (President)

Dr. Li Zhu (Chief Strategy Officer)

Non-Executive Director

Dr. Luquan Wang ("Dr. Larry Wang")

Independent Non-Executive Directors

Mr. Zumian Dai ("Mr. Edward Dai")

Mr. Jiuan Pan ("Mr. Ethan Pan")

Mr. Yiu Leung Andy Cheung

Dr. Chenyang Shi ("Dr. Victor Shi")

Dr. Alphonse Galdes

Dr. Ross Grossman

Dr. John Quelch

The Board has established five committees, and the directors of the Company are serving on the respective committees as below:

| Board Committee
Director | Audit Committee | Remuneration Committee | Nomination Committee | Risk Management and ESG Committee | Strategy Committee |
| --- | --- | --- | --- | --- | --- |
| Dr. Frank Zhang | / | / | / | C | C |
| Mr. Robin Meng | / | / | C | / | / |
| Ms. Sally Wang | / | M | M | / | / |
| Dr. Li Zhu | / | / | / | / | / |
| Dr. Larry Wang | / | / | / | / | / |
| Mr. Edward Dai | C | C | M | / | M |
| Mr. Ethan Pan | M | / | M | M | M |
| Mr. Yiu Leung Andy Cheung | M | / | M | M | / |
| Dr. Victor Shi | / | M | M | / | M |
| Dr. Alphonse Galdes | M | / | / | / | / |
| Dr. Ross Grossman | / | M | / | / | / |
| Dr. John Quelch | / | / | / | / | M |


Notes:

C: Chairman of the relevant Board committees
M: Member of the relevant Board committees

Hong Kong, 11 March 2025